Biosensor R&D start-up Delta Diagnostics has received a seed investment from two innovators: research organisation TNO – The Netherlands Organisation for Applied Scientific Research – and PhotonDelta, an ecosystem of photonic chip technology organisations.
With this funding, Delta Diagnostics can improve and evaluate its biosensor technologies in order to get ready for a Series A funding round later this year.
To read the full article, please visit: www.med-technews.com
Posted by:
Cure Talent